(Q40769996)

English

Antiparkinsonian agents and long-term neuroleptic treatment. Effect of G 31.406, orphenadrine, and placebo on parkinsonism, schizophrenic symptoms, depression and anxiety

scientific article

Antiparkinsonian agents and long-term neuroleptic treatment.

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Antiparkinsonian agents and long-term neuroleptic treatment. Effect of G 31.406, orphenadrine, and placebo on parkinsonism, schizophrenic symptoms, depression and anxiety (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

0 references

0 references

parkinsonian syndrome

1 reference

based on heuristic

inferred from title

author name string

Gerlach J

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Rasmussen PT

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Hansen L

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Kristjansen P

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

1 April 1977

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Acta Psychiatrica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

251-260

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB00170.X

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB00170.X

21 January 2018

Antiparkinsonian agents and depot phenothiazine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB00170.X

21 January 2018

Antiparkinson Drug Overuse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB00170.X

21 January 2018

Reversal of antiparkinsonian drug toxicity by physostigmine: a controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB00170.X

21 January 2018

Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB00170.X

21 January 2018

Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB00170.X

21 January 2018

A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1977.TB00170.X

21 January 2018

Identifiers

10.1111/J.1600-0447.1977.TB00170.X

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

release_hasclvbrurdijpqavnphjfsa4y

1 reference

https://api.fatcat.wiki/v0/release/hasclvbrurdijpqavnphjfsa4y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40769996&oldid=1906933273"